Brief: Aslan Pharmaceuticals Announces Plan To Implement ADS Ratio Change
14/06/2024 22:49
June 14 (Reuters) - Aslan Pharmaceuticals Ltd
7A90y.BE :
* ASLAN PHARMACEUTICALS LTD -ASLAN PHARMACEUTICALS ANNOUNCES
PLAN
TO IMPLEMENT ADS RATIO CHANGE
* ASLAN PHARMACEUTICALS-PLAN TO CHANGE RATIO OF ADSS TO ITS
ORDINARY SHARES TO ONE ADS REPRESENTING 200 ORDINARY SHARES
* ASLAN PHARMACEUTICALS-EFFECT OF RATIO CHANGE ON ADS
TRADING
PRICE ON NASDAQ CAPITAL MARKET IS EXPECTED TO TAKE PLACE AT
OPENING OF TRADING ON JULY 3
Source text for Eikon: ID:n0001193125-24-161691
Further company coverage: 7A90y.BE
((Reutersbriefs@thomsonreuters.com;))
Recent news on Aslan Pharmaceuticals
See all newsBrief: Aslan Pharmaceuticals Announces Plan To Implement ADS Ratio Change
Brief: Aslan Pharmaceuticals Ltd Files For Shelf Of Up To 61.9 Million Ordinary Shares By Selling Stockholder - SEC Filing
Brief: Aslan Pharmaceuticals Announces Expansion Of Its Collaboration With Zenyaku
Brief: Aslan Pharmaceuticals Announces Positive Interim Results From Phase 2 Study Of Eblasakimab
Brief: ASLAN Pharmaceuticals To Sell ADSs Having An Aggregate Offering Price Of Up To $12 Mln